ITP
Iron Triangle Partners Portfolio holdings
AUM
$703M
1-Year Est. Return
27.44%
1 Year Est. Return
+27.44%
AUM
$703M
AUM Growth
+$71.4M
(+11%)
Holding
37
Top Buys
| 1 | +$57.2M | |
| 2 | +$37.8M | |
| 3 | +$36.1M | |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$26.8M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$19.8M |
Top Sells
| 1 | +$36.7M | |
| 2 | +$36.4M | |
| 3 | +$32.6M | |
| 4 |
HCA Healthcare
HCA
|
+$30.6M |
| 5 |
Insulet
PODD
|
+$21.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CVS Health
CVS
$98.5B
| $60.2M | 8.55% |
797,900
+47,900
|
|
||
2
DexCom
DXCM
$25.1B
| $57.2M | 8.13% |
+850,000
|
|
||
3
AbbVie
ABBV
$397B
| $46.4M | 6.6% |
200,326
-49,671
|
|
||
4
Medtronic
MDT
$131B
| $43.2M | 6.14% |
453,347
+53,347
|
|
||
5
Charles River Laboratories
CRL
$8.6B
| $41.9M | 5.96% |
268,000
-52,000
|
|
||
6
Eli Lilly
LLY
$936B
| $37.8M | 5.38% |
+49,555
|
|
||
7
BrightSpring Health Services
BTSG
$6.34B
| $36.6M | 5.21% |
1,238,520
+38,520
|
|
||
8
Repligen
RGEN
$9.29B
| $36.1M | 5.13% |
+270,000
|
|
||
9
Glaukos
GKOS
$6.09B
| $28M | 3.98% |
342,804
+71,641
|
|
||
10
Tenet Healthcare
THC
$18.9B
| $27.9M | 3.97% |
137,448
-52,552
|
|
||
11
Exact Sciences
EXAS
$19.2B
| $27.4M | 3.89% |
500,000
+200,000
|
|
||
12
Adaptive Biotechnologies
ADPT
$2.85B
| $27.2M | 3.87% |
1,820,915
+325,032
|
|
||
|
13
Madrigal Pharmaceuticals
MDGL
$13B
| $26.8M | 3.81% |
+58,378
|
|
||
14
Guardant Health
GH
$13.5B
| $25M | 3.55% |
400,000
+100,000
|
|
||
15
Brookdale Senior Living
BKD
$2.61B
| $24M | 3.42% |
2,838,361
+1,138,361
|
|
||
16
Cardinal Health
CAH
$48.7B
| $21.7M | 3.08% |
138,011
+32,754
|
|
||
|
17
Jazz Pharmaceuticals
JAZZ
$10.1B
| $19.8M | 2.81% |
+150,000
|
|
||
18
Neurocrine Biosciences
NBIX
$15.2B
| $18.4M | 2.62% |
+131,390
|
|
||
19
West Pharmaceutical
WST
$19.6B
| $18.4M | 2.61% |
+70,000
|
|
||
20
AdaptHealth
AHCO
$1.28B
| $17.2M | 2.45% |
1,924,132
+4,113
|
|
||
21
Veracyte
VCYT
$3.65B
| $16.7M | 2.37% |
+485,000
|
|
||
22
Amicus Therapeutics
FOLD
$3B
| $15.5M | 2.21% |
+1,971,260
|
|
||
23
Doximity
DOCS
$9.52B
| $15.4M | 2.18% |
210,000
-261,300
|
|
||
24
IDEAYA Biosciences
IDYA
$2.95B
| $7.35M | 1.04% |
+270,000
|
|
||
25
argenx
ARGX
$56.4B
| $7.3M | 1.04% |
9,900
-5,667
|
|